J9263 HCPCS code: Injection, oxaliplatin, 0.5 mg
J9263 is the HCPCS Level II code for injection, oxaliplatin, 0.5 mg. In 2024 Medicare paid an average of $0.06 per service for J9263 across 20,410,899 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 700 per day on outpatient hospital claims. Medicare volume fell 5% from 2022 to 2024 (21,517,086 to 20,410,899 services). In 2024, about 4,047 clinicians billed Medicare for J9263 for 12,164 beneficiaries; Texas, Florida, California accounted for 37% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 2004-01-01 |
| Last action effective | 2018-01-01 |
Who bills J9263 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 4,047 |
| Medicare beneficiaries | 12,164 |
| States with claims | 49 |
| Share of services in top 3 states (Texas, Florida, California) | 37% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9263, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 21,517,086 | 12,846 | $0.06 | $0.05 |
| 2023 | 20,971,094 | 12,455 | $0.07 | $0.06 |
| 2024 | 20,410,899 | 12,164 | $0.07 | $0.06 |
States with the most J9263 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Texas | 2,603,554 | $0.06 |
| Florida | 2,498,879 | $0.06 |
| California | 2,406,968 | $0.06 |
| Illinois | 1,021,781 | $0.06 |
| Virginia | 905,276 | $0.06 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 700 | Clinical: Data |
| practitioner claims | 700 | Clinical: Data |
What changed for J9263
- 2004-01-01: J9263 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9263?
J9263 is the HCPCS Level II code for injection, oxaliplatin, 0.5 mg. Short descriptor: "Oxaliplatin".
How much does Medicare pay for J9263?
In 2024, the average Medicare payment was $0.06 per service (average allowed $0.07).
Does Medicare cover J9263?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J9263 can be billed per day?
700 on outpatient hospital claims; 700 on practitioner claims (NCCI medically unlikely edits).
Related J92 codes
- J9200 — Injection, floxuridine, 500 mg
- J9201 — Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
- J9202 — Goserelin acetate implant, per 3.6 mg
- J9203 — Injection, gemtuzumab ozogamicin, 0.1 mg
- J9204 — Injection, mogamulizumab-kpkc, 1 mg
- J9205 — Injection, irinotecan liposome, 1 mg
- J9206 — Injection, irinotecan, 20 mg
- J9207 — Injection, ixabepilone, 1 mg
- J9208 — Injection, ifosfamide, 1 gram
- J9209 — Injection, mesna, 200 mg
- J9210 — Injection, emapalumab-lzsg, 1 mg
- J9211 — Injection, idarubicin hydrochloride, 5 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9263
- Watch J9263 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9263
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.